Mobile health Network Solutions (NASDAQ: MNDR)’s stock price has decreased by 0.00% compared to its previous closing price of $1.11. However, the company has seen a -0.98% decrease in its stock price over the last five trading sessions. newsfilecorp.com reported 2025-06-16 that Singapore, Singapore–(Newsfile Corp. – June 16, 2025) – Mobile-health Network Solutions (Nasdaq: MNDR) (“MNDR” or “the Company”), a leading MedTech innovator ranked among Asia-Pacific’s high-growth companies, today announced financial results for the first six months of its fiscal year 2025 (“H1 FY2025”). H1 FY2025 performance: Short-term impact from transition to leaner, stronger model For the period ended December 31, 2024, the company reported: Revenue of US$4.3 million, compared to US$6.6 million for the same prior period (“H1 FY2024”) Net earnings of US$(1.7 million), compared to US$(1.5 million) in H1 FY2024 Cash and cash equivalents were at US$2.6 million, compared to US$6.7 million in H1 FY2024 The lower revenue was mainly due to a drop in the use of MNDR’s telemedicine services from the year-ago period, following the closure of its CityGate clinic in Singapore.
Is It Worth Investing in Mobile health Network Solutions (NASDAQ: MNDR) Right Now?
Moreover, the 36-month beta value for MNDR is -2.76. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy”, 0 as “overweight”, 0 as “hold”, and 0 as “sell”.
The public float for MNDR is 2.38M and currently, short sellers hold a 2.81% of that float. On July 04, 2025, MNDR’s average trading volume was 154.11K shares.
MNDR’s Market Performance
MNDR’s stock has seen a -0.98% decrease for the week, with a -18.38% drop in the past month and a -38.33% fall in the past quarter. The volatility ratio for the week is 6.03%, and the volatility levels for the past 30 days are at 7.20% for Mobile health Network Solutions The simple moving average for the past 20 days is -10.41% for MNDR’s stock, with a -56.90% simple moving average for the past 200 days.
MNDR Trading at -16.88% from the 50-Day Moving Average
After a stumble in the market that brought MNDR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -91.27% of loss for the given period.
Volatility was left at 7.20%, however, over the last 30 days, the volatility rate increased by 6.03%, as shares sank -15.91% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -21.83% lower at present.
During the last 5 trading sessions, MNDR fell by -0.98%, which changed the moving average for the period of 200-days by -82.16% in comparison to the 20-day moving average, which settled at $1.2387. In addition, Mobile health Network Solutions saw -90.36% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
N/A, the N/A of Mobile health Network Solutions, N/A N/A shares at N/A during a trade that took place back on N/A, which means that N/A is holding N/A shares at N/A based on the most recent closing price.
Stock Fundamentals for MNDR
Current profitability levels for the company are sitting at:
- -1.0% for the present operating margin
- -0.08% for the gross margin
The net margin for Mobile health Network Solutions stands at -0.99%. The total capital return value is set at -2.51%.
Based on Mobile health Network Solutions (MNDR), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at -17.04.
Currently, EBITDA for the company is -15.55 million with net debt to EBITDA at 0.51. When we switch over and look at the enterprise to sales, we see a ratio of -0.12. The receivables turnover for the company is 66.53for trailing twelve months and the total asset turnover is 1.52. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.04.
Conclusion
To wrap up, the performance of Mobile health Network Solutions (MNDR) has been bad in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
